MARKET

GOVX

GOVX

Geovax Labs Inc
NASDAQ
1.140
+0.040
+3.65%
Opening 13:19 09/30 EDT
OPEN
1.120
PREV CLOSE
1.100
HIGH
1.180
LOW
1.080
VOLUME
597.97K
TURNOVER
373.53K
52 WEEK HIGH
5.61
52 WEEK LOW
0.5495
MARKET CAP
28.21M
P/E (TTM)
-0.3830
1D
5D
1M
3M
1Y
5Y
'Ohio reports state's first death from monkeypox, raising U.S. death toll to 3' -BNO Report
https://twitter.com/BNOFeed/status/1575847127166713860
Benzinga · 15h ago
U.S. CDC Director Walensky Says U.S. Moving To Pre-exposure Prophylaxis Strategy For Monkeypox Vaccine
- Reuters 
Benzinga · 2d ago
COIN,RIOT and MARA are among pre market gainers
Ayala Pharmaceuticals (AYLA) +30% <a href="https://seekingalpha.com/...
Seekingalpha · 3d ago
Eton Pharmaceuticals, GeoVax Labs And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Nasdaq Composite dropped by around 200 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Benzinga · 4d ago
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.
Benzinga · 4d ago
GeoVax Shares Up 23%; Co Reports In Form4 Filing Director Randal Chase Bought 10K Shares At Average Price Of $1.10/Share
-SEC Filing
Benzinga · 09/23 17:39
European Union Drug Regulator European Medicines Agency Says Monkeypox Infection Trend Gives Hope That The Outbreak Can Be Contained
- Reuters 
Benzinga · 09/20 13:45
Earlier Announced: China Records First Monkeypox Case
The infected patient, who had arrived in Chongqing from overseas, developed symptoms while in Covid quarantine China has been on high alert for the disease since it started spreading rapidly in Europe and the Americas
Benzinga · 09/16 14:51
More
About GOVX
GeoVax Labs, Inc. is a clinical-stage biotechnology company. The Company is focused on developing human vaccines and immunotherapies against infectious diseases and cancer using its platforms. Its product pipeline includes ongoing human clinical trials for COVID-19 and head and neck cancer. The Company is developing a number of vaccines and immunotherapies for prevention or treatment of infectious diseases and cancers. The Company’s product candidate includes GEO-CM04S1, GEO-CM02, Gedeptin, MVA-VLP-MUC1, GEO-ZM02, GEO-EM01, GEO-LM01 and GEO-MM02. Its research and development programs include preventive vaccines against Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa) and malaria, as well as immunotherapies for multiple solid tumors. The Company’s wholly owned subsidiaries include GeoVax, Inc. and Immutak Oncology, Inc.

Webull offers kinds of Geovax Labs Inc stock information, including NASDAQ:GOVX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GOVX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GOVX stock methods without spending real money on the virtual paper trading platform.